Muscle growth peptide research often centers on pathways involved in growth hormone signaling, IGF-1 activity, muscle protein regulation, tissue repair, and myostatin-related mechanisms. Peptides such as CJC-1295, Ipamorelin, and Sermorelin are commonly studied in relation to growth hormone release and downstream IGF-1 signaling, while IGF-1 LR3 and PEG-MGF are more closely associated with muscle repair and hypertrophy-related research pathways. Follistatin is often discussed in relation to myostatin inhibition, a pathway involved in muscle mass regulation.
The strength of evidence varies significantly by peptide. Some research is based on human or clinical studies, while other findings come from laboratory, animal, or early-stage research. These products are best described as compounds with research relevance to muscle biology, growth hormone signaling, and tissue-repair pathways, not as treatments, anabolic agents, performance enhancers, or guaranteed muscle-building solutions.
Example peptides:
CJC-1295 / Ipamorelin
Sermorelin
IGF-1 LR3
PEG-MGF
Follistatin
BPC-157
Muscle Growth Research
Recommended article:
“Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults”
PLEASE NOTE: Peptides are intended for in vitro and analytical studies only and are not approved by the FDA for human or veterinary use or for the diagnosis, treatment, cure, or prevention of any disease.